Drug Database
Back to search

Netherlands· NL-f2ef02664169

Lapatinib PharOS 250 mg, filmomhulde tabletten

A lapatinib product containing lapatinibditosilaat 1-water, registered in Netherlands by Pharos Pharmaceutical Oriented Services Ltd. The same ATC class is registered in 12 of our 19 countries.

ATC L01EH01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLapatinib PharOS 250 mg, filmomhulde …ATCL01EH01REGISTER NO.NL-f2ef02664169PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lapatinibditosilaat 1-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lapatinib is registered in 12 of 19 countries.

Countries holding a registration under ATC L01EH01 (lapatinib), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search lapatinib products by name

Lapatinib · ATC L01EH01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lapatinib costs, country by country.

Normalised to the WHO defined daily dose (1.25 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Lapatinib · price per daily dose (1.25 g)

USD · FX 28 Sept 2026

  • CH Switzerland$101.12
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LAPATINIBDITOSILAAT 1-WATER
Manufacturer
Pharos Pharmaceutical Oriented Services Ltd
Country
Netherlands (NL)
ATC code
L01EH01
ATC class
Lapatinib
Defined daily dose
1.25 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    128547

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

675 interactions on record for lapatinib.

Graded by severity as the source publishes them — 124 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lapatinib against other medicinesHow interaction checks work

Lapatinib · interactions on record

675 records

  • 124 severe
  • 537 moderate
  • 14 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • LoperamideA07DA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L01EH01

Lapatinib, as other registers publish it.

All lapatinib products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5df4929-22d9-41d3-8a2a-ffccd8bdda1c
GET /v1/drugs/c5df4929-22d9-41d3-8a2a-ffccd8bdda1c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h128547_smpc_en.pdf",
  "strength": null,
  "atc_label": "Lapatinib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128547",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POLYSORBAAT 80 (E 433)",
    "POVIDON K 30 (E 1201)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "LAPATINIBDITOSILAAT 1-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128547_piluk.pdf",
  "authorised_at": "2022/07/12",
  "procedure_number": "NL/H/5466/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "128547",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about lapatinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console